Medicare Enrolled

Dr. Prodromos Borboroglu, M.D.

Urology Physician · West Melbourne, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Mixed engagement
575 S WICKHAM RD, West Melbourne, FL 32904
3213085060
In practice since 2006 (20 years)
NPI: 1770543894 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Borboroglu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borboroglu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Borboroglu

Dr. Prodromos Borboroglu is an urology physician in West Melbourne, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Borboroglu performed 7,530 Medicare services across 3,693 unique beneficiaries.

Between the years covered by Open Payments, Dr. Borboroglu received a total of $1,855 from 10 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Borboroglu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 16% volume in FL $1,855 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 99271 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
7,530
Medicare services
Top 16% in FL for urology physician
3,693
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~376 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Genetic analysis to identify organisms
A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms.
2,652 $34 $70
Nucleic acid test for multiple organisms
A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample.
663 $69 $140
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
588 $91 $221
Yeast/candida DNA test
A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample.
442 $34 $70
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
442 $34 $70
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
345 $61 $151
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
243 $82 $249
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
221 $34 $70
Staphylococcus aureus DNA test
A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample.
221 $34 $70
MRSA nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
221 $34 $70
Strep A nucleic acid amplification test
A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present.
221 $34 $70
Group B Strep DNA test
A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria.
221 $34 $70
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
139 $120 $334
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
80 $28 $410
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
77 $6 $116
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
76 $600 $2,218
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
72 $297 $716
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
72 $147 $366
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
72 $8 $43
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
58 $74 $223
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
52 $9 $35
Endoscopic destruction of bladder, urethra, or gland tissue
A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands.
48 $574 $2,348
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
45 $40 $113
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
39 $37 $153
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
36 $170 $414
Bladder tumor removal via endoscope
This procedure involves using an endoscope to destroy or remove a large growth from the bladder.
24 $252 $786
Prostate tissue destruction using microwave heat
This procedure destroys prostate tissue by applying heat generated through microwave energy.
22 $1,061 $5,862
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
22 $138 $240
Bladder stone removal, less than 2.5 cm
A procedure to crush, fragment, and remove bladder stones that are smaller than 2.5 centimeters.
21 $685 $1,800
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
19 $88 $862
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
19 $578 $1,596
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
19 $19 $36
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
16 $338 $881
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
11 $103 $467
Sacral nerve stimulator electrode insertion
A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves.
11 $852 $2,305
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
6.6% medium
93.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,855
Total received (2018-2024)
Avg $265/year across 7 years
Bottom 35% in FL for urology physician
10
Companies
23
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$1,500 (80.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$355 (19.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,602
2023
$49
2022
$13
2021
$21
2020
$17
2019
$81
2018
$73

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$1,500
Astellas Pharma US Inc
$124
Medtronic, Inc.
$91
Axonics, Inc.
$45
Janssen Biotech, Inc.
$25
KARL STORZ Endoscopy-America
$17
Teleflex LLC
$16
Coloplast Corp
$15
Allergan Inc.
$11
180 Medical, Inc.
$11
Top 3 companies account for 92.4% of total payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · Axonics · Axonics r-SNM System · BOTOX THERAPEUTIC · Erleada · GENTLECATH · INTERSTIM · MYRBETRIQ · Myrbetriq · Titan · UROLIFT · VISERA ELITE II VIDEO SYSTEM CENTER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Equivalent to $25 per 100 Medicare services performed
Looking for an urology physician in West Melbourne?
Compare urology physicians in the West Melbourne area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
27
Per 100K population
4.4
County median income
$75,817
Nearest hospital
PALM BAY HOSPITAL
8.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Borboroglu is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), with mixed engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Borboroglu experienced with genetic analysis to identify organisms?
Based on Medicare claims data, Dr. Borboroglu performed 2,652 genetic analysis to identify organisms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borboroglu receive payments from pharmaceutical companies?
Yes. Dr. Borboroglu received a total of $1,855 from 10 companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borboroglu's costs compare to other urology physicians in West Melbourne?
Dr. Borboroglu's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borboroglu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →